U.S. Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Software
Riskified Ltd (RSKD) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth Amid Macroeconomic Challenges
Riskified Ltd (RSKD) reports 8% revenue growth and positive adjusted EBITDA, but anticipates softer quarters ahead due to macroeconomic headwinds. Aug 15, 2024
GuruFocus Research Real Estate
Smith Douglas Homes Corp (SDHC) Q2 2024 Earnings Call Transcript Highlights: Strong Home Closings and Revenue Growth Amid Market Challenges
Smith Douglas Homes Corp (SDHC) reports a 17% increase in home closings and robust financial performance despite market headwinds. Aug 15, 2024
GuruFocus Research Biotechnology
Outlook Therapeutics Inc (OTLK) Q3 2024 Earnings Call Transcript Highlights: Key Financial Metrics and Strategic Updates
Discover the latest financial performance, strategic initiatives, and future outlook from Outlook Therapeutics Inc (OTLK) in their Q3 2024 earnings call. Aug 15, 2024
GuruFocus Research Biotechnology
Protalix BioTherapeutics Inc (PLX) Q2 2024 Earnings Call Transcript Highlights: Revenue Decline and Strategic Updates
Protalix BioTherapeutics Inc (PLX) reports a challenging quarter with decreased revenues but remains optimistic about future growth and strategic initiatives. Aug 15, 2024
GuruFocus Research Biotechnology
bluebird bio Inc (BLUE) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Expansions
bluebird bio Inc (BLUE) reports significant revenue increase and expanded treatment centers, but faces challenges in cash runway and revenue recognition timelines. Aug 15, 2024
GuruFocus Research Tobacco Products
22nd Century Group Inc (XXII) Q2 2024 Earnings Call Transcript Highlights: Significant Reduction in Net Loss and Revenue Growth Initiatives
Despite ongoing challenges, 22nd Century Group Inc (XXII) shows promising signs of financial turnaround and strategic rebranding efforts. Aug 15, 2024